Immune Design Corporation

116 articles about Immune Design Corporation

• Immune Design Corporation Appoints Richard T. Kenney, M.D., Chief Medical Officer

  9/5/2013

• Immune Design Corporation and Medicago, Inc. Announce License Agreement and Collaboration to Develop Novel Adjuvanted Pandemic Influenza Vaccines

  6/28/2013

• SCYNEXIS, Inc. and Immune Design Corporation Collaborate on Innovative Process for Vaccine Production Technology

  4/10/2013

• Immune Design Corporation Announces the Grant of Two Principle Technology Patents and a Recent Publication in the Proceedings of the National Academy of Sciences

  10/9/2012

• Immune Design Corporation to Present at 3rd Annual Cancer Immunotherapy Conference

  10/3/2012

• Immune Design Corporation Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer

  12/5/2011

• Immune Design Corporation and Sanofi-Aventis Announce Research Collaboration

  10/27/2011

• Immune Design Corporation Appoints Guy F. Cipriani as Chief Business Officer

  10/18/2011

• Immune Design Corporation Rakes in Another $11 Million from Prior VC Round

  10/6/2011

• Immune Design Corporation, Developer of New Vaccines, Adds Former Elan Corporation PLC President as New CEO

  4/27/2011

• Immune Design Corporation Snags $212M Deal With MedImmune To Provide Vaccine Booster

  10/26/2010

• Immune Design Corporation Raises $32 Million in Series B Financing

  7/26/2010

• So Much For Gardening: Bruce Carter Joins Vaccine Startup Immune Design Corporation To Raise Cash

  11/23/2009

• Immune Design Corporation Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director

  11/23/2009

• Infectious Disease Research Institute (IDRI) and Immune Design Corporation Enter License Agreement on GLA Vaccine Adjuvant

  11/21/2008

• Immune Design Announces $18 Million Series A Financing

  6/23/2008